pharma Β· RSV Infection Β· NASH - Nonalcoholic Steatohepatitis Β· ENTA
ENANTA PHARMACEUTICALS
ENANTA PHARMACEUTICALS INC
ENANTA PHARMACEUTICALS trial registry β 46 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 4 Kingsbury Ave, Watertown, Massachusetts 02472, US
- Founded
- 1995
- Employees
- 145
- Programs
- 34
- Drugs
- 15
- Patents
- 218
ENANTA PHARMACEUTICALS clinical trials
Registry index of 46 ClinicalTrials.gov studies linked to ENANTA PHARMACEUTICALS programs β each row shows trial ID, program name, phase, status, and indication.
ENANTA PHARMACEUTICALS trial registry β 46 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for ENANTA PHARMACEUTICALS.
-
Fluconazole β Phase 1
Clinical update -
EDP-305 Dose 1 β Phase 2
Clinical update -
EDP-938 β Phase 2
Clinical update -
EDP-514 β Phase 1
Clinical update -
EDP-235 β Phase 2
Clinical update -
EDP-938, EDP-938 Placebo tablets β Phase 2
Clinical update -
zelicapavir (therapeutic dose) β Phase 1
Clinical update -
intraconazole β Phase 1
Clinical update
Trial registry
-
CTIS β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β